Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Effects of KSM on the Cytotoxicity of Amyloid β Protein and the APP's Molecular Weight

가미신선불로단이 알츠하이머병 진단지표인 아리로이드 단백독성과 APPr에 미치는 영향

  • Eom Hyun Sup (Department of Oriental Medicine, Dongeui University)
  • Published : 2004.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

In order to evaluate the neuroprotective effects of Kamisinsunbulo-dan(KSM), the cytotoxicity of amyloid β and the recovering effect of KSM were checked at first. Then the viability of C6 cells was tested in comparison with each concentration of KSM. The cytotoxicity of amyloid β(31-35) showed from 5 μM higher to 100 μM. And the recovering effect by KSM showed significantly at 100㎍/㎖. concentration. And the cell viability was shown significantly over 200 ㎍/㎖ of KSM. This is thought that the viability has some relation to length of culturing duration, 6 to 12 hrs. Lastly in the western blotting of APP, the amount of low molecule's APP was decreased. So the APP form ratio(APPr) changed to increase, and it meant that KSM can be used to lower the toxic APP, and can be a candidate for Alzheimer's disease.

Keywords

References

  1. The International Journal of Biochemistry & Cell Biology v.35 no.11 Amyloid precursor protein(APP) and the biology of proteolytic processing: relevance to Alzheimer's disease Yan Ling;Kevin Morgan;Noor Kalsheker https://doi.org/10.1016/S1357-2725(03)00133-X
  2. Neuron v.32 New frontiers in Alzheimer's disease genetics Tanzi, R.E.;Bertram, L.
  3. Applied Pathology v.2 The amyloid deposits in Alzheimer's disease: Their nature and pathogenesis Glenner, G.G.;Wong, C.W.;Quaranta, V.;Eanes, E.D.
  4. Physiological Reviews v.81 Alzheimer's disease: Genes, proteins, and therapy Selkoe, D.J. https://doi.org/10.1152/physrev.2001.81.2.741
  5. Neurol Sci. v.23 Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms B. Borroni(et al) https://doi.org/10.1007/s100720200042
  6. 동의생리병리학회지 v.16 no.6 가미신선불로단이 ibotenic acid손상에 의해 유도된 치매 백서의 학습 및 기억장애에 미치는 영향 엄현섭
  7. Nature v.325 The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Kang J.;Lemaire, H.G.;Unterbeck, A.;Salbaum, J.M.;Masters, C.L.;Grzeschik, K.H.;Multhaup, G.;Beyreuther, K.;Muller-Hill, B.
  8. Gene v.87 Genomic organization of the human amyloid beta-protein precursor gene Yoshikai, S.;Sasaki, H.;Doh-ura, K.;Furuya, H.;Sakaki, Y.
  9. Nature v.359 Isolation and quantitation of soluble Alzheimer's-peptide from biological fluids Seubert P.;Vigo-Pelfrey, C.;Esch, F.;Lee, M.;Dovey, H.;Davis, D.;Sinha, S.;Schlossmacher, M.G.;Whaley, J.;Swindlehurst, C.;McCormack, R.;Wolfert, R.;Selkoe, D.J.;Lieberburg, I.;Schenk, D.
  10. Nature v.359 Amyloid-$\beta$ peptide is produced by cultured cells during normal metabolism Haass, C.;Schlossmacher, M.;Hung, A.Y.;Vigo-Pelfrey, C.;Mellon, A.;Ostazewski, B.;Lieberburg, I.;Koo, E.H.;Schenk, D.;Teplow, D.;Selkoe, D.J.
  11. The Journal of Biological Chemistry v.277 Oligomeric and fibrillar species of amyloid-$\beta$ peptides differentially affect neuronal viability Dahlgren, K.N.;Manelli, A.M.;Stine Jr.W.B.;Baker, L.K.;Kraft, G.A.;LaDu, M.J. https://doi.org/10.1074/jbc.M201750200
  12. Peptides v.23 Correlation between beta-amyloid peptide production and human APP-induced neuronal death Kienlen-Campard P.;Octave, J.N. https://doi.org/10.1016/S0196-9781(02)00055-4
  13. Neurol Sci. v.23 no.5 Early stages of probable Alzheimer disease are associated with changes in platelet amyloid precursor protein forms Borroni B;Colciaghi F;Corsini P;Akkawi N;Rozzini L;Del Zotto E;Talarico G;Cattabeni F;Lenzi GL;Di Luca M;Padovani A https://doi.org/10.1007/s100720200042
  14. Eur Neuropsychopharmacol. v.12 no.3 ApoE genotypeinfluences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model Borroni B;Colciaghi F;Pastorino L;Archetti S;Corsini P;Cattabeni F;Di Luca M;Padovani A https://doi.org/10.1016/S0924-977X(02)00013-5
  15. Int J Mol Med. v.11 no.2 The impact of risk factors of Alzheimer's disease in the Down syndrome Folin M;Baiguera S;Conconi MT;Pati T;Grandi C;Parnigotto PP;Nussdorfer GG